Quarterly-results cover filed; the actual financial update is missing

The filing itself contains no operating results. The supplied text only says Pulse Biosciences announced financial and operational results for the quarter ended June 30, 2026; the substantive press release and tables are referenced as Exhibit 99.1 but are not included here. (Item 2.02)

There is no defensible beat-or-miss read yet. Without the exhibit, the filing provides no revenue, loss, cash balance, spending, guidance, clinical milestones, or other new information to compare with market expectations. (Exhibit 99.1 referenced but not supplied)